Giulia Smecca

Dr. Giulia Smecca

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
FBFrancesca Baglio
Francesca Baglio
Federica RossettoFederica Rossetto
Federica Rossetto
EGElisa Gervasoni
Elisa Gervasoni
ICIlaria Carpinella
Ilaria Carpinella
GSGiulia Smecca
Giulia Smecca
FGFIT4TeleNEURO Working Group
FIT4TeleNEURO Working Group
Parkinson’s disease (PD) and multiple sclerosis (MS) are two chronic neurological diseases (CNDs) that have a high demand for early and continuous rehabilitation. However, accessing professional care remains a challenge, making it a key priority to identify sustainable solutions for ensuring early rehabilitation availability. Objective: The FIT4TeleNEURO pragmatic trial proposes to investigate, in real-life care settings, the superiority in terms of the effectiveness of early rehabilitation intervention with harmonized, mix-model telerehabilitation (TR) protocols (TR single approach, task-oriented—TRsA; TR combined approach, task-oriented and impairment-oriented—TRcA) compared to conventional management (control treatment, CeT) in people with PD and MS. Design, and Methods: This multicenter, randomized, three-treatment arm pragmatic trial will involve 300 patients with CNDs (PD, N = 150; MS, N = 150). Each participant will be randomized (1:1:1) to the experimental groups (20 sessions of TRsA or TRcA according to a mix-model—3 asynchronous + 1 synchronous session/week) or the control group (20 sessions of CeT). Primary and secondary outcome measures will be obtained at the baseline (T0), post-intervention (T1, 5 weeks after baseline), and follow-up (T2, 3 months after the end of the treatment). A multidimensional evaluation (cognitive, motor, and quality of life domains) will be conducted at each time point of assessment (T0; T1; T2). The primary outcome measures will be the assessment of change (T0 vs. T1 vs. T2) in static and dynamic balance, measured using the Mini-Balance Evaluation Systems Test. Usability and acceptability assessment will be also investigated. Expected Results: Implementing TR protocols will enable a more targeted and efficient response to the growing demand for rehabilitation in the early stages of CNDs. Both the TRsA and TRcA approaches are expected to be more effective than CeT, with the combined approach likely providing greater benefits in secondary outcome measures. Finally, the acceptability of the asynchronous modality could open the door to scalable solutions, such as digital therapeutics.

2 February 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SISara Isernia
Sara Isernia
GSGiulia Smecca
Giulia Smecca
Federica RossettoFederica Rossetto
Federica Rossetto
Francesca BorgnisFrancesca Borgnis
Francesca Borgnis
FBFrancesca Baglio
Francesca Baglio
Social cognition (SC) impairment is a hallmark of the cognitive profile in Multiple Sclerosis (MS). However, there is a still no consensus on recommended measures for SC phenotyping in this clinical population, limiting our understanding of underlying mechanism and the development of targeted intervention. This study evaluated the suitability of the Edinburgh Social Cognition test (ESCoT), a novel ecologically valid tool assessing affective (ToMA) and cognitive (ToMc) Theory of Mind, as well as interpersonal (SNUINTER) and intrapersonal (SNUINTRA) social norm understanding, for SC phenotyping in MS. Seventy-one participants (39 with MS and 32 healthy controls) completed a neuropsychological battery including both non-social (Stroop test, Digit Span) and socio-cognitive (Eyes Test, ESCoT) measures. ESCoT demonstrated strong diagnostic validity (AUC = 0.803), outperforming the Eyes test (AUC = 0.653). Notably, ESCoT captured the peculiarity SC impairment profile in MS, marked by a dissociation between affective and cognitive ToM (ToMA< ToMc; group*ToM domain interaction: F = 21.87, p < 0.001), and between interpersonal and intrapersonal SNU (SNUINTER< SNUINTRA: group*SNU domain interaction: F = 22.76, p < 0.001). In the MS group, ToMA and ToMc scores were associated with the working memory, while SNUINTRA score was linked to executive functioning. These findings support ESCoT as a valid tool for SC phenotyping in MS.